5-Hydroxy-1-methylhydantoin
CAS No. 84210-26-4
5-Hydroxy-1-methylhydantoin( NZ-419 | HD-003 )
Catalog No. M27907 CAS No. 84210-26-4
NZ-419 is an antioxidant potentially for the treatment of renal failure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 44 | In Stock |
|
| 25MG | 89 | In Stock |
|
| 50MG | 138 | In Stock |
|
| 100MG | 207 | In Stock |
|
| 200MG | 305 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5-Hydroxy-1-methylhydantoin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNZ-419 is an antioxidant potentially for the treatment of renal failure.
-
DescriptionNZ-419 is an antioxidant potentially for the treatment of renal failure. A creatinine metabolite, NZ-419, a hydroxyl radical scavenger, has previously been shown to confer renoprotection by inhibiting the progression of chronic kidney disease in rats. NZ-419 a novel anti-oxidant drug completely suppressed the expression of B2-kinin receptors (B2KR) in response to high glucose (25 mM) stimulation in VSMC and was also shown to attenuate the effects of BK on VSMC remodeling. NZ-419 inhibited the BK-induced increase in MAPK phosphorylation and attenuated the increase in connective tissue growth factor (CTGF) protein levels in VSMC. These findings suggest that NZ-419 may confer vascular protection against high glucose concentrations and BK-stimulation to ameliorate vascular injury and remodeling through its anti-oxidant properties.
-
In Vitro——
-
In Vivo——
-
SynonymsNZ-419 | HD-003
-
PathwayGPCR/G Protein
-
TargetBradykinin Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84210-26-4
-
Formula Weight114.1
-
Molecular FormulaC4H6N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC(CN1C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dana M, et al. Synthesis of homoveratric acid-imprinted polymers and their evaluation as selective separation materials. Molecules. 2011 May 5;16(5):3826-44.
molnova catalog
related products
-
Lys-Bradykinin aceta...
Lys-Bradykinin acetate is an endogenous bradykinin receptor agonist.
-
Icatibant Acetate
Icatibant Acetate, an antagonist of the bradykinin B2 receptor, is used in the treatment of hereditary angioedema.
-
B-Raf IN 14
B-Raf IN 14 is a BRAF inhibitor.
Cart
sales@molnova.com